§ 13F · FUND PROFILE
Propel Bio Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $100M (13F)Positions · 16Turnover · — · Q1Filed · May 14, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$53M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | 1.27M | $30M | 19.0% | ±0% |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | 3.79M | $11M | 7.2% | ±0% |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | 841K | $9M | 5.9% | +14% |
| 4 | DCTH | DELCATH SYS INC | 980K | $9M | 5.8% | +123% |
| 5 | CORT | CORCEPT THERAPEUTICS INC | 148K | $6M | 3.8% | NEW |
| 6 | ABEO | ABEONA THERAPEUTICS INC | 1.33M | $6M | 3.8% | +60% |
| 7 | VOR | VOR BIOPHARMA INC | 315K | $6M | 3.5% | NEW |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | 644K | $6M | 3.5% | −3% |
| 9 | MIST | MILESTONE PHARMACEUTICALS IN | 4.12M | $5M | 3.2% | ±0% |
| 10 | CLDX | CELLDEX THERAPEUTICS INC NEW | 131K | $4M | 2.6% | −15% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PROPEL SIGNAL
AC read
Propel Bio Management, LLC is a Other fund managing $100 million in assets. The fund runs a focused portfolio of just 16 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed